Investor Deck

Learn how AEGIS became the world's first EPICARDIAL ONLY left atrial appendage seclusion tool. Learn more about Sierra and how it stacks up against it's peers.

Market assessment
Patented device overview
Peer analysis
Team and management
Why AEGIS